Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Mader

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|February 21, 2025
Ravulizumab and other complement inhibitors for the treatment of autoimmune disordersGabriel de Deus Vieira, Vinícius Oliveira Boldrini, Simone Mader, et al.
Trends in Immunology|October 24, 2015
Antibodies as Mediators of Brain PathologyLior Brimberg, Simone Mader, Yuichiro Fujieda, et al.
Multiple Sclerosis and Related Disorders|October 7, 2019
Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from SerbiaJelena Drulovic, Vanja Martinovic, Irena Dujmovic Basuroski, et al.
Plos One|January 21, 2016
Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus NerveGerard Honig, Simone Mader, Huiyi Chen, et al.
Journal of Translational Autoimmunity|November 18, 2020
Serological comparison of systemic lupus erythematosus with neuropsychiatric lupus using synthetic nucleic acid antigensSangita Khatri, Nikos Psaraftis, Alessia Funaro, et al.
Annals of Neurology|April 24, 2023
MOG-IgG-Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox VaccinationDaniel Engels, Simone Mader, Stefanie Förderreuther, et al.
Journal of Neuroimmunology|February 15, 2011
Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disordersIrena Dujmovic, Simone Mader, Kathrin Schanda, et al.
Clinical Immunology (Orlando, Fla.)|December 21, 2010
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseasesFranziska Di Pauli, Simone Mader, Kevin Rostasy, et al.
Acta Neuropathologica Communications|November 21, 2013
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive ratsMaja Kitic, Sonja Hochmeister, Isabella Wimmer, et al.
Journal of the Neurological Sciences|March 26, 2013
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseasesViktoria Gredler, Simone Mader, Kathrin Schanda, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|February 21, 2025
Ravulizumab and other complement inhibitors for the treatment of autoimmune disordersGabriel de Deus Vieira, Vinícius Oliveira Boldrini, Simone Mader, et al.
Trends in Immunology|October 24, 2015
Antibodies as Mediators of Brain PathologyLior Brimberg, Simone Mader, Yuichiro Fujieda, et al.
Multiple Sclerosis and Related Disorders|October 7, 2019
Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from SerbiaJelena Drulovic, Vanja Martinovic, Irena Dujmovic Basuroski, et al.
Plos One|January 21, 2016
Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus NerveGerard Honig, Simone Mader, Huiyi Chen, et al.
Journal of Translational Autoimmunity|November 18, 2020
Serological comparison of systemic lupus erythematosus with neuropsychiatric lupus using synthetic nucleic acid antigensSangita Khatri, Nikos Psaraftis, Alessia Funaro, et al.
Annals of Neurology|April 24, 2023
MOG-IgG-Associated Bilateral Optic Neuritis in Temporal Relation to Monkeypox VaccinationDaniel Engels, Simone Mader, Stefanie Förderreuther, et al.
Journal of Neuroimmunology|February 15, 2011
Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disordersIrena Dujmovic, Simone Mader, Kathrin Schanda, et al.
Clinical Immunology (Orlando, Fla.)|December 21, 2010
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseasesFranziska Di Pauli, Simone Mader, Kevin Rostasy, et al.
Acta Neuropathologica Communications|November 21, 2013
Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive ratsMaja Kitic, Sonja Hochmeister, Isabella Wimmer, et al.
Journal of the Neurological Sciences|March 26, 2013
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseasesViktoria Gredler, Simone Mader, Kathrin Schanda, et al.
Pageof 5